813 results on '"Stevenson, William G."'
Search Results
2. Response to the invited manuscript
3. Intramural needle ablation or repeated standard ablation in patients referred for repeat ablation of scar‐related ventricular tachycardia
4. Safety of Ventricular Arrhythmia Radiofrequency Ablation with Half-Normal Saline Irrigation
5. Stroke and Bleeding Risks of Endocardial Ablation for Ventricular Arrhythmias
6. EP Corner: Oscillations
7. Termination Without Global Capture in Reentrant Ventricular Tachycardia
8. Multisize Electrode Field-of-View
9. Diagnostic Impact and Prognostic Value of Cardiac Magnetic Resonance in Patients With Ventricular Arrhythmias
10. Abstract 15689: Ablation for Atrial Fibrillation in Patients With Rare Pathogenic Variants in Cardiomyopathy and Arrhythmia Genes
11. Tissue inhibitors of metalloproteinases are proteolytic targets of matrix metalloproteinase 9
12. The Shape of Ventricular Tachycardia
13. Intracardiac thrombi fluttering like hair in the wind at VT ablation
14. The Continuing Saga of Tissue Inhibitor of Metalloproteinase 2
15. Ischemic Ventricular Tachycardia
16. Sarcoid Ventricular Tachycardia
17. Idiopathic Dilated Cardiomyopathy Ventricular Tachycardia
18. Mapping and Ablation of Ventricular Arrhythmias
19. Whole organism profiling of the Timp gene family
20. Cardiac Sarcoidosis and a Likely Pathogenic TTN Variant in a Patient Presenting With Ventricular Tachycardia
21. PO-01-044 THEOPHYLLINE FOR TREATMENT OF PAINFUL LEFT BUNDLE BRANCH BLOCK
22. LB-456089-3 WORLD WIDE EXPERIENCE WITH AN END-HOLE IRRIGATED NEEDLE CATHETER FOR ABLATION OF REFRACTORY VENTRICULAR ARRHYTHMIAS: FINAL REPORT
23. Oral theophylline for treatment of painful left bundle branch block
24. PO-04-186 ASSESSING PROXIMITY TO THE VENTRICULAR TACHYCARDIA CIRCUIT EARLY IN THE PACING TRAIN: NUMBER NEEDED TO RESET
25. PO-04-235 STEREOTACTIC RADIOTHERAPY FOR THE TREATMENT OF RECURRENT REFRACTORY VT IN CHAGAS DISEASE PATIENTS
26. CE-452777-3 VENTRICULAR TACHYCARDIA PREDICTS ALL-CAUSE MORTALITY AND NON-SUDDEN CARDIAC DEATH IN NON-ISCHAEMIC CARDIOMYOPATHY
27. PO-05-098 CAN INTRACARDIAC ECHO HELP AVOID STEAM POPS DURING HALF NORMAL SALINE IRRIGATED VENTRICULAR ARRHYTHMIAS ABLATION?
28. PO-04-195 NOT JUST FOR THE YOUNG: GENETIC TESTING IN OLDER PATIENTS WITH NONISCHEMIC CARDIOMYOPATHY AND VENTRICULAR TACHYCARDIA
29. World Wide Experience with An End-Hole Irrigated Needle Catheter for Ablation of Refractory Ventricular Arrhythmias
30. AB-452673-2 REPEAT STANDARD ABLATION OR INTRAMURAL NEEDLE ABLATION AFTER FAILED STANDARD ABLATION FOR VENTRICULAR TACHYCARDIA
31. PO-04-193 RIGHT ATRIUM TO LEFT VENTRICLE ACCESS FOR VENTRICULAR TACHYCARDIA ABLATION IN PATIENTS WITH DOUBLE MECHANICAL VALVES: FEASIBILITY, SAFETY AND OUTCOMES IN A MULTICENTER REGISTRY
32. Abstract 2348: Mapping the interactome of matrisome targets using extracellular proximity labeling (ePL)
33. Sustained monomorphic ventricular tachycardia: the role of catheter ablation
34. Anesthesiology Considerations for the Electrophysiology Laboratory
35. Contributors
36. Catheter Ablation for Ventricular Tachycardia With or Without Structural Heart Disease
37. Foreword
38. Preface
39. Supplementary Tables 1-4, Figure Legends 1-2 from Nm23-H1 Suppresses Tumor Cell Motility by Down-regulating the Lysophosphatidic Acid Receptor EDG2
40. Data from Nm23-H1 Suppresses Tumor Cell Motility by Down-regulating the Lysophosphatidic Acid Receptor EDG2
41. Supplementary Figure 1 from Nm23-H1 Suppresses Tumor Cell Motility by Down-regulating the Lysophosphatidic Acid Receptor EDG2
42. Supplementary Tables 1-4, Figure Legends 1-2 from Nm23-H1 Suppresses Tumor Cell Motility by Down-regulating the Lysophosphatidic Acid Receptor EDG2
43. Supplementary Figure 1 from Nm23-H1 Suppresses Tumor Cell Motility by Down-regulating the Lysophosphatidic Acid Receptor EDG2
44. Supplementary Figure 2 from Nm23-H1 Suppresses Tumor Cell Motility by Down-regulating the Lysophosphatidic Acid Receptor EDG2
45. Supplementary Figure 2 from Nm23-H1 Suppresses Tumor Cell Motility by Down-regulating the Lysophosphatidic Acid Receptor EDG2
46. Data from Nm23-H1 Suppresses Tumor Cell Motility by Down-regulating the Lysophosphatidic Acid Receptor EDG2
47. REMEMBER THE TITIN: CARDIAC SARCOIDOSIS AND A LIKELY PATHOGENIC VARIANT IN TTN IN A PATIENT PRESENTING WITH VENTRICULAR TACHYCARDIA
48. SURVEY OF PROVIDER OPINIONS ON GENETIC EVALUATION OF EARLY ONSET ATRIAL FIBRILLATION
49. Substrate Mapping Alters Ventricular Tachycardia Inducibility
50. Cheating death in a maze of surgical ablation data
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.